-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on enGene Holdings, Lowers Price Target to $30

Benzinga·03/11/2026 19:20:52
Listen to the news
Oppenheimer analyst Leland Gershell maintains enGene Holdings (NASDAQ:ENGN) with a Outperform and lowers the price target from $33 to $30.